Today's Health News
Most Inflammatory, Cardiac Manifestations of MIS-C Resolve
Most inflammatory markers normalized by one to four weeks; however, elevated double-negative T cells seen in 92 percent at one to four months
Survival Up for Multiple Cancer Types for Teens, Young Adults
Limited or no improvement seen in female breast cancer, cervical cancer, ovarian cancer, and bone and joint sarcomas
Vaccinations Start to Climb in States Hit Hard by Delta Variant
Variant, which first emerged in India, now accounts for an estimated 83 percent of coronavirus samples genetically identified in the United States
Circulation of Respiratory Viruses Low During COVID-19 Pandemic
Influenza activity decreased in March 2020, remained low through May 2021; decrease seen in other viruses, with no increase until Spring 2021
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices
Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery
Prior Statin Use Linked to Reduced Risk for Death in COVID-19
Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension
2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth
Mortality due to COVID-19 had biggest effect on decline in life expectancy for both men and women, all races examined
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease
Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19
For those at high risk, COVID-19-related hospitalization or death from any cause reduced with bamlanivimab/etesevimab versus placebo